Trials / Sponsors / AltruBio Inc.
AltruBio Inc.
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Particip Ulcerative Colitis (UC) | Phase 1 | 2025-11-17 |
| Active Not Recruiting | Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics Ulcerative Colitis | Phase 2 | 2023-12-04 |
| Completed | A First-In-Human SAD and MAD Study to Evaluate the Safety, Tolerability, PK and PD of SC Administered ALTB-268 Healthy Volunteers | Phase 1 | 2023-01-17 |
| Completed | Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refra Steroid-refractory Acute Graft-versus-Host Disease, Treatment-refractory Acute Graft-versus-Host Disease | Phase 1 | 2018-05-31 |
| Terminated | Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Ref Ulcerative Colitis | Phase 2 | 2018-05-04 |